Management of End Stage Cardiac Failure
Overview
Authors
Affiliations
Optimum heart failure medication and an increasing array of interventions have had an enormous effect on morbidity and mortality over the past 10 years. However, patients with end stage disease can still be highly symptomatic. Moreover, such patients are disadvantaged compared with patients with malignant disease. They are less likely to have an understanding of their illness or have access to supportive care. They are also less likely to have the opportunity to plan for care with regard to death and dying. There is increasing demand that the multi-professional clinical team gain good communication and supportive care skills, and that appropriate access to specialist palliative care services is available.
Relation of sedentary behaviour to physical function in phase I cardiac rehabilitation.
Izawa K, Kanejima Y, Kitamura M, Ishihara K, Ogura A, Kubo I Sci Rep. 2023; 13(1):9387.
PMID: 37296206 PMC: 10256782. DOI: 10.1038/s41598-023-36593-4.
Kanejima Y, Izawa K, Kitamura M, Ishihara K, Ogura A, Kubo I Int J Environ Res Public Health. 2022; 19(24).
PMID: 36554430 PMC: 9779210. DOI: 10.3390/ijerph192416550.
Fayez S, Mishlish S, Saied H, Shaban S, Suleiman A, Hassan F Biomed Res Int. 2022; 2022:2738119.
PMID: 36187500 PMC: 9519277. DOI: 10.1155/2022/2738119.
Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study.
Munoz M, Calero E, Duran J, Navas E, Alonso S, Argemi N J Clin Med. 2022; 11(9).
PMID: 35566406 PMC: 9101156. DOI: 10.3390/jcm11092280.
Effect of Dietary Education Program on Health Status of Heart Failure Patients.
Khudhur Y, Mohammed Y Iran J Public Health. 2021; 50(7):1515-1516.
PMID: 34568201 PMC: 8426778. DOI: 10.18502/ijph.v50i7.6655.